Jim Edwards, At B|Net Pharma, On Nuvaring® MDL Expansion Of Suits

Do go read Jim’s piece, here — on the tripling of the number of lawsuits that allege blood clots resulted from use of the legacy Schering-Plough (nee Organon) Nuvaring® birth control drug/device:

. . . .The claims against Nuvaring are similar to those against the patch: Because the device delivers a constant stream of hormone unmediated by the digestive system or the liver, patients end up getting higher doses than they do from older pills. High estrogen doses create a greater risk of blood clots, which can be fatal. . . .

An earlier East Texas press report may be found here. We’ll keep an eye on this, but as of now, it is barely material to New Merck’s financial results. I guess the trend-line is troubling, though.

There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: